Shares of Telomir Pharmaceuticals climbed up 20% to $5.10 after the company said it saw positive pre-clinical results confirming the efficacy of its licensed molecule Telomir-1 in reversing several ...
An injectable weight-loss drug can reduce type 2 diabetes risk in people with obesity and prediabetes by roughly 90%, a new study has indicated. Researchers have found that tirzepatide can protect ...